How new CLL medicines may leave no patient behind
Dr Barbara Eichhorst, a noted chronic lymphocytic leukaemia (CLL) expert from Cologne, Germany, feels the latest news on promising therapies for CLL will benefit a wide group of patients, including th... Author: PatientPowerEU Added: 01/05/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 5, 2015 Category: Cancer & Oncology Source Type: podcasts

How the new paradigm of treatment offers hope to a wide range of CLL patients
Dr Stephan Stilgenbauer, an expert in chronic lymphocytic leukaemia (CLL) from Ulm, Germany, discusses the new age of care for a wide range of CLL patients. He defines ‘ultra high-risk CLL’, which... Author: PatientPowerEU Added: 01/05/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 5, 2015 Category: Cancer & Oncology Source Type: podcasts

Expert Perspectives: Chronic Lymphocytic Leukemia
Recent advances in clinical and basic research identifying underlying genetic and biological events associated with the pathology of hematologic malignancies have yielded numerous therapeutic innovati... Author: imedex Added: 01/04/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 5, 2015 Category: Cancer & Oncology Source Type: podcasts

CLL: It's the Best -- and Most Confusing -- of Times
Dr Bruce Cheson and Dr Susan O'Brien discuss data presented at the 2014 ASH meeting on chronic lymphocytic leukemia, with a focus on the CLL10 trial as well as ibrutinib, idelalisib, and ADT-199. (Source: Medscape Oncology)
Source: Medscape Oncology - December 17, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Bruce Gimplin: CLL Is Just Part of Who I Am
Bruce Gimplin, a clinical social worker and psychotherapist, helps people work through their worries and fears. But Bruce had to face his own when he was diagnosed with chronic lymphocytic leukemia (C... Author: patientpower Added: 12/12/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2014 Category: Cancer & Oncology Source Type: podcasts

CLL: Idelalisib based regimens
Chronic lymphocytic leukemia (CLL) is the most common lymphoid malignancy in the western world and has a highly variable course. Advances in diagnosis, risk assessment and front-line treatment options... Author: imedex Added: 11/30/2014 (Source: Oncology Tube)
Source: Oncology Tube - November 30, 2014 Category: Cancer & Oncology Source Type: podcasts

CLL: Chemotherapy and Ibrutinib based regimens
Chronic lymphocytic leukemia (CLL) is the most common lymphoid malignancy in the western world and has a highly variable course. Advances in diagnosis, risk assessment and front-line treatment options... Author: imedex Added: 11/30/2014 (Source: Oncology Tube)
Source: Oncology Tube - November 30, 2014 Category: Cancer & Oncology Source Type: podcasts

How Are SLL and CLL Different?
Often, patients wonder, "What is small lymphocytic leukemia (SLL) and how does it differ from chronic lymphocytic leukemia (CLL)?" A leading CLL expert, Dr. John Pagel, explains the biology ... Author: patientpower Added: 09/22/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 23, 2014 Category: Cancer & Oncology Source Type: podcasts

Dr. John Byrd Discusses the Treatment Landscape for CLL
John C. Byrd, MD, a professor of Medicine at The Ohio State University Comprehensive Cancer Center, discusses the promising treatment landscape for patients with chronic lymphocytic leukemia. View ... Author: onclivetv Added: 09/10/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2014 Category: Cancer & Oncology Source Type: podcasts

CLL and the Risks of Richter's Syndrome
MD Anderson expert Dr. Michael Keating discusses the chance of contracting Richter's syndrome with chronic lymphocytic leukemia (CLL). He also explains the prognosis after diagnosis with CLL. Produce... Author: patientpower Added: 08/26/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 27, 2014 Category: Cancer & Oncology Source Type: podcasts

Risks Associated with Transplant in CLL
Chronic lymphocytic leukemia (CLL) expert Dr. Januario Castro explores the role of transplant in CLL treatment, how it works, and the risks associated with this procedure. He describes the types of tr... Author: patientpower Added: 08/26/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 27, 2014 Category: Cancer & Oncology Source Type: podcasts

Ask the Expert: What is CLL vs. SLL?
A world-renowned CLL expert from MD Anderson Cancer Center, Dr. William Wierda, explains the difference between CLL (chronic lymphocytic leukemia) and SLL (small lymphocytic lymphoma). He also discuss... Author: patientpower Added: 08/23/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2014 Category: Cancer & Oncology Source Type: podcasts

What is CLL?
What is chronic lymphocytic leukemia (CLL)? Dr. Michael Keating, an expert from MD Anderson Cancer Center, explains the disease and what is going on with the cells in your body when you have CLL. Dr. ... Author: patientpower Added: 08/23/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2014 Category: Cancer & Oncology Source Type: podcasts

CLL's 'Very Unusual Year'
Dr. Bruce Cheson discusses how to choose among the new, exciting options available for the treatment of chronic lymphocytic leukemia: obinutuzumab, ibrutinib, and idelalisib. (Source: Medscape Oncology)
Source: Medscape Oncology - August 20, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Chronic Lymphocytic Leukemia CLL Moon Shot update
Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses n... Author: mdanderson Added: 08/07/2014 (Source: Oncology Tube)
Source: Oncology Tube - August 7, 2014 Category: Cancer & Oncology Source Type: podcasts